Neuland Laboratories Ltd Q1 FY25 consolidated PAT surges to Rs. 97.87 crores

Neuland Laboratories Limited has reported Consolidated financial results for the period ended June 30, 2024.

Financial Results (Q1 FY2025) - QoQ Comparison

The company has reported total income of Rs. 444.4087 crores during the period ended June 30, 2024 as compared to Rs. 390.3667 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs. 97.8727 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. 67.5619 crores for the period ended March 31, 2024.

The company has reported EPS of Rs. 76.28 for the period ended June 30, 2024 as compared to Rs. 52.66 for the period ended March 31, 2024.

Financials	Q1 FY2025	Q4 FY2024	% Change
Total Income	₹ 444.4087 crs	₹390.3667 crs	13.84%
Net Profit	₹97.8727 crs	₹67.5619 crs	44.86%
EPS	₹76.28	₹52.66	44.85%

Financial Results (Q1 FY2025) - YoY Comparison

The company has reported total income of Rs. 444.4087 crores during the period ended June 30, 2024 as compared to Rs.365.0328 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs.97.8727 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.61.8790 crores for the period ended June 30, 2023.

The company has reported EPS of Rs.76.28 for the period ended June 30, 2024 as compared to Rs.48.23 for the period ended June 30, 2023.

Financials	Q1 FY2025	Q1 FY2024	% Change
Total Income	₹ 444.4087 crs	₹365.0328 crs	21.74%
Net Profit	₹97.8727 crs	₹61.8790 crs	58.17%
EPS	₹76.28	₹48.23	58.16%

Shares of Neuland Laboratories Limited was last trading in BSE at Rs. 9373.10 as compared to the previous close of Rs. 8748.50. The total number of shares traded during the day was 5595 in over 1268 trades.

The stock hit an intraday high of Rs. 9646.35 and intraday low of 8728.65. The net turnover during the day was Rs. 51300823.00.

Source : Equity Bulls

Keywords

NeulandLaboratories Q1FY25 FY2025 Q1FY2025 ResultUpdate